| Literature DB >> 24879374 |
Tomàs M Pérez-Porcuna1, Carlos Ascaso2, Adriana Malheiro3, Rosa Abellana4, Marilaine Martins5, José Felipe Jardim Sardinha5, Patricia Quincó6, Irineide Assumpção Antunes7, Marlucia da Silva Garrido8, Samira Bührer-Sékula9, Flor Ernestina Martinez-Espinosa10.
Abstract
OBJECTIVE: This study evaluated the performance of the Tuberculin Skin Test (TST) and Quantiferon-TB Gold in-Tube (QFT) and the possible association of factors which may modify their results in young children (0-6 years) with recent contact with an index tuberculosis case.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24879374 PMCID: PMC4039466 DOI: 10.1371/journal.pone.0097992
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow diagram of enrolment (QFT: QuantiFERON-TB Gold In-Tube).
Baseline demographic and clinical data of the study participants.
| Individuals evaluated | All Results | |
|
| 135 | 46 (28.0; 64.5) |
| Less than 24 months | 31 (23.0%) | |
|
| 135 | |
| Male | 61 (45.2%) | |
| Female | 74 (54.8%) | |
|
| 130 | 118 (90.8%) |
|
| 133 | 130 (97.7%) |
|
| 135 | 105 (77.8%) |
|
| 135 | 61 (45.2%) |
|
| 135 | 1.5 (0.2–3.7) |
|
| 135 | 11 (6.3; 13.0) |
|
| 130 | 44 (33.8%) |
|
| 135 | 28 (20.7%) |
|
| 135 | 71 (52.6%) |
|
| 135 | 12 (8.9%) |
|
| 105 | 30 (28.6%) |
|
| 129 | −0.13 (−0.9; 0.5) |
|
| 129 | |
| Risk of malnutrition | 19 (14.7%) | |
| Malnutrition | 11 (8.5%) | |
|
| 135 | 31.9 (21.6; 45.9) |
|
| 135 | 38.1 (24.6; 48.8) |
|
| 135 | |
| Strong reaction (≥10 mm) | 47 (34.8%) | |
| Weak reaction (5–9 mm) | 0 (0.0%) | |
| No reaction (0–4 mm) | 88 (65.2%) | |
|
| 135 | |
| Positive | 36 (26.7%) | |
| Negative | 80 (59.3%) | |
| Hyperactivity of the negative control | 10 (7.4%) | |
| No reactivity of the positive control | 9 (6.7%) |
TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: Mycobacterium tuberculosis contact score, BCG: Bacillus Calmette-Guérin.
Categorical variables expressed as number of subjects (n) and percentage (%) compared to those evaluated with the characteristic studied. Quantitative variables expressed as mean and interquartile range (IQR).
In the 12 weeks prior to the study.
Risk of malnutrition was defined as a Z score for weight less than −1 SDs for age and gender; malnutrition was defined −2 SDs for age and gender.
Comparison of the TST and QFT results.
| QFT results | ||||||
| Positive | Negative | Indeterminate | Indeterminate | Total | ||
| Hyporeactive | Hyperreactive | n (%) | ||||
|
| Positive | 21 | 18 | 2 | 6 | 47 (34.8%) |
| Negative | 15 | 62 | 7 | 4 | 88 (65.2%) | |
| Total n (%) | 36 (26.7%) | 80 (59.3%) | 9 (6.7%) | 10 (7.4%) | 135 (100.0%) | |
TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, n: number of subjects.
Bivariate analysis and Multivariate logistic regression for TST results and QFT results.
| TST results | QFT results | |||||||||
| Bivariate | Multivariate | Bivariate | Multivariate | |||||||
| Positive | Negative |
|
| Odds Ratio | Positive | Negative |
|
| Odds Ratio | |
| N = 39 | N = 77 | (95% CI) | N = 36 | N = 80 | (95% CI) | |||||
| Age (months) | 45.0 | 46.0 | 0.863 | 0.729 | - | 47.5 | 44.0 | 0.241 | 0.412 | - |
| (26.0, 60.0) | (24.0, 65.0) | (32.0, 66.5) | (23.0, 62.0) | |||||||
| Gender (male) | 46.2% | 40.3% | 0.544 | 0.906 | - | 41.7% | 43.2% | 0.876 | 0.665 | - |
| BCG scar | 94.9% | 90.5% | 0.418 | 0.244 | - | 97.2% | 89.7% | 0.169 | 0.560 | - |
| Time of exposure (months) | 4.0 | 1.0 | <0.001 | 0.009 | 1.15 | 2.0 | 1.0 | 0.024 | 0.537 | - |
| (1.0, 10.0) | (0.0, 3.0) | (1.04; 1.27) | (1.0–5.2) | (0.0–3.0) | ||||||
| MTC-score | 12.0 | 10 | <0.001 | 0.005 | 1.29 | 12.0 | 10.0 | 0.021 | 0.035 | 1.16 |
| (8.2, 14.0) | (0.0,12,0) | (1.08; 1.54) | (8.0, 14.0) | (0.0, 12.0) | (1.01; 1.33) | |||||
| Passive Smokers | 50.0% | 27.4% | 0.017 | 0.323 | - | 41.7% | 32.9% | 0.365 | 0.728 | - |
| Previous infection | 15.4% | 26.0% | 0.196 | 0.203 | - | 16.7% | 24.7% | 0.335 | 0.836 | - |
| Previous vaccination | 59.0% | 49.4% | 0.327 | 0.078 | - | 55.6% | 50.6% | 0.622 | 0.631 | - |
| Previous corticoid therapy | 15.4% | 6.5% | 0.123 | 0.199 | - | 11.1% | 8.6% | 0.673 | 0.801 | - |
| Helminth infection | 42.9% | 25.0% | 0.091 | 0.252 | - | 21.4% | 36.1% | 0.167 | 0.324 | - |
| Z scores for weight-for-age and gender | −0.1 | −0.3 | 0.800 | 0.990 | - | −0.3 | −0.1 | 0.317 | 0.858 | - |
| (−1.0, 0.3) | (−0.9, 0.5) | (−1.0, 0.3) | (−0.9, 0.5) | |||||||
| Ferritin level (ng/mL) | 35.2% | 30.6 | 0.243 | 0.767 | - | 29.9 | 35.4 | 0.323 | 0.705 | - |
| (26.4, 48.4) | (20.8, 44.7) | (22.3, 40.8) | (21.6, 49.9) | |||||||
| Vitamin D level (ng/mL) | 40 | 35.5 | 0.097 | 0.963 | - | 37.7 | 35.7 | 0.736 | 0.227 | - |
| (26.8, 59.8) | (23.8, 46.3) | (26.0, 49.1) | (24.4, 48.9) | |||||||
TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: Mycobacterium tuberculosis contact score, BCG: Bacillus Calmette-Guérin.
Categorical variables expressed as percentage (%) and quantitative variables expressed as mean and interquartile range (IQR).
In the 12 weeks prior to the study.
Linear odds ratio.
Figure 2Odds ratio and confidence interval of 95% for the Tuberculin Skin Test –TST− (blue) and QuantiFERON-TB Gold in-Tube –QFT− (red) positive results according to the intensity of exposure to index case by Mycobacterium tuberculosis contact score (MTC-score).
The MTC-score is from 0 to 15 and is based on the assumption that the gradient of Mtb exposure is a composite function of the infectivity of the index case (0–4), the duration of exposure -hours per day- (0–4), the relationship to index case (0–4) and the type of exposure (0–3).
Figure 3Odds ratio and confidence interal of 95% for the Tuberculosis Skin Test positive results according to time of exposure (months) to index case.
Multivariate logistic regression according to factors for positive QFT results stratified by TST results.
| TST+ | TST− | |||||
|
| Regression | Odds Ratio |
| Regression | Odds Ratio | |
| Coefficient | (95% CI) | Coefficient | (95% CI) | |||
| Time of exposure (months) | 0.667 | - | 0.593 | - | ||
| MTC-score | 0.020 | 0.547 | 1.727 | 0.288 | - | |
| (0.234) | (1.091; 2.735) | |||||
| Helminth infection | 0.049 | −2.752 | 0.064 | 0.895 | - | |
| (1.395) | (0.004; 0.983) | |||||
| Ferritin level | 0.143 | - | 0.036 | −0.045 | 0.956 | |
| (0.021) | (0.916; 0.997) | |||||
TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: Mycobacterium tuberculosis contact score, BCG: Bacillus Calmette-Guérin.
logistic regression coefficient related to quantitative variable.
Linear odds ratio; exponential to the regression coefficient.
Comparison of the main variables according to TST and QFT results.
| MTC-score | Time of exposure | Ferritin | Helminths | |||||
| Test results | N1 | Median | IQR | Median | IQR | Median | IQR | % (n/N2) |
| TST+&QFT+ | 21 | 12.50 | 10.25–14.75 | 4.00 | 1.00–12.00 | 34.35 | 24.15–65.60 | 25.0 (4/16) |
| TST+&QFT− | 18 | 11.50 | 8.00–13.75 | 6.71 | 1.00–7.50 | 35.40 | 27.15–41.50 | 66.7 (8/12) |
| TST−&QFT+ | 15 | 10.00 | 7.00–12.00 | 2.00 | 1.00–4.00 | 26.60 | 17.10–31.90 | 16.7 (2/12) |
| TST−&QFT− | 62 | 9.50 | 0.00–12.00 | 1.00 | 0.00–3.00 | 31.00 | 21.00–57.70 | 27.1 (13/48) |
IQR: interquartile range,
N1: number of subjects, TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: Mycobacterium tuberculosis contact score, n: number of subjects with intestinal helminths;
N2: number of subjects studied for helminths.
Figure 4Box-plot of ferritin levels (ng/mL) according to TST−&QFT+ (n = 15) and TST−&QFT− (n = 62) groups.
Tuberculin Skin Test (TST) and QuantiFERON-TB Gold in-Tube (QFT).